Are your patients
with metastatic
castrate-resistant
prostate cancer
eligible for a Phase III
clinical trial?
Now enrolling patients
with metastatic
castrate-resistant
prostate cancer
Learn more about
a Phase III clinical
trial in prostate
cancer
© 2017 Genentech USA, Inc. All rights reserved. BIO/062717/0106